Memory T cells and their costimulators in human allograft injury

SL Shiao, JM McNiff, JS Pober - The Journal of Immunology, 2005 - journals.aai.org
SL Shiao, JM McNiff, JS Pober
The Journal of Immunology, 2005journals.aai.org
Abstract Both CD4+ and CD8+ human memory but not naive T cells respond to allogeneic
human dermal microvascular endothelial cells (HDMEC) in vitro by secreting cytokines and
by proliferating. Several recently identified costimulators, namely, 4-1BB ligand, ICOS
ligand, and OX40 ligand, are up-regulated on cultured HDMEC in response to TNF or
coculture with allogeneic T cells. Blockade of these costimulators each partially reduces IFN-
γ and IL-2 secretion and proliferation of previously resting memory T cells. The effects of …
Abstract
Both CD4+ and CD8+ human memory but not naive T cells respond to allogeneic human dermal microvascular endothelial cells (HDMEC) in vitro by secreting cytokines and by proliferating. Several recently identified costimulators, namely, 4-1BB ligand, ICOS ligand, and OX40 ligand, are up-regulated on cultured HDMEC in response to TNF or coculture with allogeneic T cells. Blockade of these costimulators each partially reduces IFN-γ and IL-2 secretion and proliferation of previously resting memory T cells. The effects of these costimulators are overlapping but not identical. Memory but not naive T cells are the principal effectors of microvascular injury in human skin allografts following adoptive transfer into immunodeficient mice. Furthermore, blocking 4-1BB ligand, ICOS ligand, or OX40 ligand in this model reduces human skin allograft injury and T cell effector molecule expression. These data demonstrate that human memory T cells respond to microvascular endothelial cells and can injure allografts in vivo without priming. Furthermore, several recently described costimulators contribute to these processes.
journals.aai.org